Table 1 Summary of AML gene expression data sets retrieved from GEO and TCGA/Cancer Browser databases.
From: SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness
Accession number | Platform | Patients (N)a | Ageb | Cytogenetics |
|---|---|---|---|---|
GSE12417, cohort 1 | Affymetrix, HG-U133A | 162 | 58 (17–83) | Normal |
GSE12417, cohort 2 | Affymetrix, HG-U133_Plus_2 | 78 | 62 (18–85) | Normal |
GSE6891, cohort 1 | Affymetrix, HG-U133_Plus_2 | 222 | 43 (15–60) | Heterogeneous |
GSE6891, cohort 2 | Affymetrix, HG-U133_Plus_2 | 185 | 45 (17–60) | Heterogeneous |
GSE37642 | Affymetrix, HG-U133A | 379 | 57 (18–83) | Heterogeneous |
GSE71014 | Illumina HumanHT-12 V4.0 | 104 | na | Normal |
TCGA_LAML | RNA-sequencing | 142 | 60 (18–88) | Heterogeneous |
